Breaking

Tel Aviv hit by missile fired from Yemen, Israel and Houthis say
What we know about the suspect behind the German Christmas market attack
30 people die in a crash between a passenger bus and a truck in Brazil
How a teenager’s holiday romance led to prison time in Dubai
Stardust Power Acquires Site, Receives Key Permit And Receives Approval For Major Construction To Commence
Tech 5: Bitcoin Drops Below US$100,000, Micron Guidance Shakes Investors
At least one killed and several embassies damaged in ‘barbaric’ Russian missile barrage on Kyiv, Ukraine says
Macron tells cyclone-hit Mayotte islanders to be grateful they are French after facing jeers

World News
Science
Investing
Business
Search for:

Investing

Completion of preclinical data package for RAD 402

December 10, 2024

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced Completion of preclinical data package for RAD 402

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Tech 5: Bitcoin Drops Below US$100,000, Micron Guidance Shakes Investors

December 22, 2024

Stardust Power Acquires Site, Receives Key Permit And Receives Approval For Major Construction To Commence

December 22, 2024

Brunswick Exploration Closes Upsized Non-Brokered Private Placement of $4.8M

December 21, 2024

Fill Out & Get More Relevant News

Your name

Your email

Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.
Categories
- Business (766)
- Investing (1,537)
- Science (573)
- World News (1,842)

Disclaimer: digitaltradecenter.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest Posts
- Privacy Policy
- Terms & Conditions

Copyright © 2024 digitaltradecenter.com | All Rights Reserved

Top

World News
Science
Investing
Business

Type above and press Enter to search. Press Esc to cancel.